BATCH-5518 · HPLC 99.08%
Growth Hormone Axis
Tesamorelin
10 mg lyophilized · single vial
Stabilized GHRH (1-44) analog studied for pituitary signaling and lipid-distribution endpoints in vitro.
Dispatch schedule
$185.00Research use only
ISO-17025 Batch VerifiedLyophilized Stability
Dosing timeline — 12-Weeks
Per-compound administration schedule across 12 weeks.
WK 1 · 1 mg / day
WK 2 · 1 mg / day
WK 3 · 2 mg / day
WK 4 · 2 mg / day
WK 5 · 2 mg / day
WK 6 · 2 mg / day
WK 7 · 2 mg / day
WK 8 · 2 mg / day
WK 9 · 2 mg / day
WK 10 · 2 mg / day
WK 11 · 1 mg / day
WK 12 · 1 mg / day
123456789101112
Titration
WK 1–2
1 mg / day
Receptor tolerance assessment
Study Arc
WK 3–10
2 mg / day
Peak IGF-1 expression window
Taper
WK 11–12
1 mg / day
Axis normalisation
Kit composition
- 10 mg lyophilized
Tesamorelin
Growth Hormone Axis
- 1 × 3 mL
Bacteriostatic Water
Reconstitution diluent
- × 30
U-100 Syringes
Precision administration